Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine
- 23 October 2004
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 178 (4) , 505-513
Abstract
Contradictory evidence exists regarding the role of the 5-HT2A receptor (5-HT2AR) in hyperactivity and hyperthermia elicited by the substituted amphetamine (+)-3,4-methylenedioxymethamphetamine. The present studies examined the ability of the selective 5-HT2AR antagonist M100907 to block hyperactivity and hyperthermia produced across the (+)-MDMA dose-effect curve. Male rats were pretreated with M100907 (0, 0.25, 0.5, 1, and 2 mg/kg) followed by treatment with (+)-MDMA (0–12 mg/kg); activity was recorded for 90 min followed by determination of rectal temperature. Additionally, we investigated the ability of M100907 (0 and 0.5 mg/kg) to reverse hyperthermia elicited by (+)-MDMA (12 mg/kg). The first study demonstrated that M100907 attenuated hyperactivity in the periphery of the monitor and eliminated rearing induced by (+)-MDMA (3 mg/kg) with no effect on basal activity. In two subsequent studies, (+)-MDMA (0–12 mg/kg) dose-dependently increased peripheral activity and rearing and produced hyperthermia. Pretreatment with M100907 decreased peripheral activity evoked by (+)-MDMA, right-shifted the dose-effect curve for rearing, and blocked (+)-MDMA-induced hyperthermia, while having no effect when administered alone. A final study demonstrated the ability of M100907 (0.5 mg/kg) to reverse hyperthermia produced by (+)-MDMA (12 mg/kg). These results suggest that the 5-HT2AR contributes to the generation of peripheral hyperactivity and rearing and, especially, the hyperthermia evoked by (+)-MDMA and that 5-HT2AR antagonists should be further investigated as treatments for the psychological and hyperthermic effects of (±)-MDMA.Keywords
This publication has 42 references indexed in Scilit:
- The Selective Serotonin-2A Receptor Antagonist M100907 Reverses Behavioral Deficits in Dopamine Transporter Knockout MiceNeuropsychopharmacology, 2003
- Discriminative stimulus properties of (±)-fenfluramine: The role of 5-HT₂ receptor subtypes.Behavioral Neuroscience, 2003
- SR46349-B, a 5-HT2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus AccumbensNeuropsychopharmacology, 2002
- The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to ratsBritish Journal of Pharmacology, 2002
- Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity, Role of 5-HT1B/1D and 5-HT2 ReceptorsNeuropsychopharmacology, 2002
- Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat StrainsNeuropsychopharmacology, 2001
- The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?The Neuroscientist, 2000
- MDMA induced hyperthermia: Report of a fatality and review of current therapyIntensive Care Medicine, 1996
- Effects of the Selective 5-HT2A Receptor Antagonist MDL 100,907 on MDMA-Induced Locomotor Stimulation in RatsNeuropsychopharmacology, 1996
- Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the ratPharmacology Biochemistry and Behavior, 1989